Absci Corporation (ABSI) IPO Opens 31% Higher

Today's IPO for Absci Corporation (NASDAQ: ABSI) opened for trading at $21 after pricing 12,500,000 shares of common stock at a public offering price of $16.00 per share.

J.P. Morgan, Credit Suisse, BofA Securities, Cowen, and Stifel are acting as lead book-running managers for the offering.

Absci is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. We built our Integrated Drug Creation™ Platform to accelerate discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to develop new protein-based drugs, including those that may be impossible to make with other technologies. Our goal is to enable the creation of better medicines by Translating Ideas into Drugs™.

You May Also Be Interested In

• Absci Corporation (ABSI) Misses Q2 EPS by 2c
• Londian Wason New Energy Tech opens at $26, above IPO price of $22
• Lyntris (LYNX) files for 24M share IPO at $19-$22/sh